Abstract
Spironolactone, a steroidal mineralocorticoid receptor antagonist, is recommended as add-on therapy for treatment-resistant/uncontrolled hypertension. However, caution is advised in patients with advanced chronic kidney disease (CKD) due to an increased risk for hyperkalemia. KBP-5074 is a nonsteroidal mineralocorticoid receptor antagonist under investigation for the treatment of treatment-resistant and uncontrolled hypertension in patients with moderate-to-severe CKD. BLOCK-CKD is a phase 2, international, multicenter, randomized, double-blind, placebo-controlled, parallel-group study to evaluate the efficacy and safety of KBP-5074, on top of current therapy, in patients with stage 3B/4 CKD (estimated glomerular filtration rate ≥15 and ≤44 mL/[min·1.73 m2]) and resistant hypertension (trough cuff seated systolic blood pressure ≥140 mm Hg, despite treatment with maximally tolerated doses of 2 or more antihypertensive medicines with complementary mechanisms). Patients (n=240) will be randomized 1:1:1 to once-daily treatment with KBP-5074 0.25 mg, KBP-5074 0.5 mg, or placebo, stratified by estimated glomerular filtration rate (≥30 versus <30 mL/[min·1.73 m2]) and systolic blood pressure (≥160 versus <160 mm Hg). Approximately 30%...Continue Reading
References
Sep 24, 2004·The New England Journal of Medicine·Alan S GoChi-yuan Hsu
Mar 3, 2007·Clinical Chemistry·Andrew S LeveyUNKNOWN Chronic Kidney Disease Epidemiology Collaboration
Dec 8, 2009·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Paul MuntnerUNKNOWN Chronic Renal Insufficiency Cohort (CRIC) Study Investigators
Sep 8, 2010·The New England Journal of Medicine·Lawrence J AppelUNKNOWN AASK Collaborative Research Group
May 9, 2012·European Journal of Heart Failure·Bertram PittFaiez Zannad
May 29, 2013·European Heart Journal·Bertram PittFaiez Zannad
Jun 28, 2013·BMC Nephrology·Andreas KuznikLisa Tarasenko
Oct 5, 2013·BMJ : British Medical Journal·T NinomiyaS MacMahon
Jul 14, 2014·Seminars in Nephrology·Ivana Lazich, George L Bakris
Feb 17, 2015·Annals of Internal Medicine·Amanda H AndersonUNKNOWN Chronic Renal Insufficiency Cohort Study Investigators
Jul 24, 2015·The Journal of Biological Chemistry·Larbi AmazitJérôme Fagart
Sep 2, 2015·JAMA : the Journal of the American Medical Association·George L BakrisUNKNOWN Mineralocorticoid Receptor Antagonist Tolerability Study–Diabetic Nephropathy (ARTS-DN) Study Group
Sep 29, 2015·Lancet·Bryan WilliamsUNKNOWN British Hypertension Society's PATHWAY Studies Group
Feb 10, 2016·Journal of Cardiovascular Pharmacology·Jana GruneUlrich Kintscher
Sep 4, 2017·American Journal of Nephrology·Allan J CollinsDavid A Bushinsky
Nov 15, 2017·Hypertension·Paul K WheltonJackson T Wright
Nov 28, 2017·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Reimar W ThomsenHenrik Toft Sørensen
Feb 14, 2018·Hypertension·Jana GruneUlrich Kintscher
Oct 26, 2018·Hypertension·Robert M CareyUNKNOWN American Heart Association Professional/Public Education and Publications Committee of the Council on Hypertension; Council
Nov 25, 2018·Journal of Clinical Medicine·Chen-Ta YangYao-Peng Hsieh
Feb 27, 2019·Drugs·Sean Duggan
Sep 20, 2019·Lancet·Rajiv AgarwalBryan Williams
Citations
Aug 18, 2020·Expert Opinion on Drug Safety·Steven G Chrysant, George S Chrysant
Sep 6, 2020·Reviews in Endocrine & Metabolic Disorders·Yanduan LinJiao Guo
Sep 29, 2020·American Journal of Physiology. Renal Physiology·Dominique M BoveeEwout J Hoorn
Nov 13, 2020·Drug Development Research·Vishal PatelMukul Jain
Dec 6, 2020·Journal of Cardiovascular Pharmacology·Christopher S Wilcox, Bertram Pitt
May 11, 2021·Hypertension·George BakrisUNKNOWN BLOCK-CKD Study Group
May 5, 2021·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Alberto OrtizUNKNOWN European Renal and Cardiovascular Medicine (EURECA-m) working group of the European Renal Association—European Dialysis and
Aug 31, 2021·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Peter KolkhofUlrich Kintscher
Nov 18, 2021·British Journal of Pharmacology·Jonatan Barrera-ChimalHans-Joachim Anders
Nov 24, 2021·British Journal of Pharmacology·Ulrich KintscherPeter Kolkhof